Dealing in securities by a Director of a Major Subsidiary AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 ("the Company" or "AfroCentric") Dealing in securities by a Director of a Major Subsidiary In compliance with the terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the Company hereby discloses the following director's dealings in AfroCentric shares relating to the acceptance of awards of shares in terms of the AfroCentric Forfeitable Share Scheme, adopted by AfroCentric at the annual general meeting held on 10 November 2022 (the "AfroCentric Forfeitable Share Scheme"): Name of Director: Andrew Schwulst Designation: Chief Executive Officer of Medscheme Holdings Proprietary Limited Date of transaction: 25 April 2024 Class of securities: Ordinary shares Number of securities obtained: 1 215 805 Value of transaction: R3 999 998.45 Price per security: R3.29 Nature of transaction: Off-market acceptance of an award of shares in terms of the AfroCentric Forfeitable Share Scheme Nature of interest: Direct beneficial Date of vesting of award: 1 November 2026 Clearance obtained: Yes Johannesburg 2 May 2024 JSE Sponsor to AfroCentric Questco Corporate Advisory Proprietary Limited Date: 02-05-2024 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.